0001179110-14-014454.txt : 20140924
0001179110-14-014454.hdr.sgml : 20140924
20140924132034
ACCESSION NUMBER: 0001179110-14-014454
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140922
FILED AS OF DATE: 20140924
DATE AS OF CHANGE: 20140924
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GILEAD SCIENCES INC
CENTRAL INDEX KEY: 0000882095
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943047598
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 6505743000
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cogan John Francis
CENTRAL INDEX KEY: 0001319872
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19731
FILM NUMBER: 141118057
MAIL ADDRESS:
STREET 1: 2010 NORTH FIRST STREET, SUITE 310
CITY: SAN JOSE
STATE: CA
ZIP: 95131
4
1
edgar.xml
FORM 4 -
X0306
4
2014-09-22
0
0000882095
GILEAD SCIENCES INC
GILD
0001319872
Cogan John Francis
333 LAKESIDE DRIVE
FOSTER CITY
CA
94404
1
0
0
0
Common Stock
2014-09-22
4
M
0
5000
14.3375
A
47405
D
Common Stock
2014-09-22
4
S
0
1896
105.7606
D
45509
D
Common Stock
2014-09-22
4
S
0
1303
106.5957
D
44206
D
Common Stock
2014-09-22
4
S
0
1801
107.4795
D
42405
D
Non-Qualified Stock Option (Right to Buy)
14.3375
2014-09-22
4
M
0
5000
0
D
2016-05-10
Common Stock
5000
66000
D
The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
Options are 100% vested on the date of grant.
Sale prices reported for the transactions reported here range from $105.31 to $106.28. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Sale prices reported for the transactions reported here range from $106.31 to $107.25. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Sale prices reported for the transactions reported here range from $107.31 to $107.54. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
/s/ John F. Milligan by Power of Attorney for John F. Cogan
2014-09-24